References
- Akkar A, Muller RH. Formulation of intravenous carbamazepine emulsions by SolEmuls technology. Eur J Pharm Biopharm 2003; 55: 305–312
- Barakat NS, Yassin AEB. In vitro characterization of carbamazepine-loaded precifac lipospheres. Drug Deliv 2006; 13: 95–104
- Baumann WJ, Mangold HK. Reactions of aliphatic methanesulfonates. I. Syntheses of long-chain glyceryl—(1) ethers. J Org Chem 1964; 29: 3055–3057
- Benita S, Levy ML. Submicron emulsions as colloidal drug carriers for intravenous administration: Comprehensive physicochemical characterization. J Pharm Sci 1993; 82: 1069–1079
- Brewster ME, Anderson W, Bodor N. Brain, blood and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits. J Pharm Sci 1991; 80: 843–846
- Buszello K, Muller BW. Emulsions as drug delivery systems. Pharmaceutical emulsions and suspensions, F Nielloud, G Marti-Mestres. Marcel Dekker Inc., New York 2000; 191–228
- De Smidt PC, Campanero MA, Troconiz IF. Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: Contribution of emulsification versus digestibility. Int J Pharm 2004; 270: 109–118
- Dierling AM, Cui Z. Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. Int J Pharm 2005; 303: 143–152
- Erdlenbruch B, Jendrossed V, Eibl H, Lakomek M. Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats. Exp Brain Res 2000; 135: 417–422
- Fisher RS, Ho J. Potential new methods for antiepileptic drug delivery. CNS Drugs 2002; 16: 579–593
- Hashida M, Kawakami S, Yamashita F. Lipid carrier systems for targeted drug and gene delivery. Chem Pharm Bull 2005; 53: 871–880
- Hunt CA, MacGregor RD, Siegel RA. Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations. Pharm Res 1986; 3: 333–344
- Jacqueline MM, Orlando DHS, Tatiani D, Pedro AR. Characterization and evaluation of electrolyte influence on canola oil/water nanoemulsion. J Dispersion Sci Technol 2006; 27: 1009–1014
- Loscher W, Honack D. Intravenous carbamazepine: Comparison of different parenteral formulations in a mouse model of convulsive status epilepticus. Epilepsia 1997; 38: 106–113
- Lundberg BB, Griffiths G, Hansen HJ. Conjugation of an anti-B-cell lymphoma monoclonal antibody, LL2, to long-circulating drug-carrier lipid emulsions. J Pharm Pharmacol 1999; 51: 1099–1105
- Magalhaes NS, Fessi H, Puisieux F, Benita S, Seiller M. An in vitro release kinetic examination and comparative evaluation between submicron emulsion and polylactic acid nanocapsules of clofibride. J Microencapsul 1995; 12: 195–205
- Mosqueira VCF, Legrand P, Morgat J, Vert M, Mysiakine E, Gref R, Devissaguet J, Barratt G. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: Effect of PEG chain length and density. Pharm Res 2001; 10: 1411–1419
- Nicolaos G, Crauste-Manciet S, Farinotti R, Brossard D. Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion. Int J Pharm 2003; 263: 165–171
- Notari RE. Pharmacokinetics. Biopharmaceutics and clinical pharmacokinetics-an introduction4th ed. Marcel dekker Inc, New York 1987; 45–128
- Shawer M, Greenspan P, OIe S, Lu DR. VLDL-resembling phospholipid-submicron emulsion for cholesterol-based drug targeting. J Pharm Sci 2002; 91: 1405–1413
- Stevens J, Mims P, Coles N. 2003. Lipid emulsions as drug delivery systems. 5th ed. business briefing: Pharmatech (May 2003). Available: http://www.touchbriefings.com/viatheINTERNET.
- Su J, He L, Zhang N, Ho PC. Evaluation of tributyrin lipid emulsion with affinity to low-density lipoprotein: Pharmacokinetics in adult male wistar rats and cellular activity on Caco-2 and HepG2 Cell lines. J Pharmacol Exp Ther 2006; 316: 62–70
- Tauboll E, Lindstrom S, Klem W. A new injectable carbamazepine solution: Antiepileptic effects and pharmaceutical properties. Epilepsy Res 1990; 7: 59–64
- Yeeprae W, Kawakami S, Higuchi Y, Yamashita F, Hashida M. Biodistribution characteristics of mannosylated and fucosylated o/w emulsions in mice. J Drug Target 2005; 13: 479–487